Living Through the Fentanyl Era: A Harm Reduction Primer
Naloxone, test strips, xylazine, and what meets people where they are without judgment.
Body: [Draft covers: what fentanyl is and isn’t, why supply contamination is the defining risk factor, naloxone step-by-step (including multi-dose scenarios with high-potency synthetics), fentanyl test strip limitations (won’t detect nitazenes), xylazine and what’s different about it, Good Samaritan laws state-by-state, and the cultural shift from abstinence-only to harm reduction. Explicitly non-judgmental; assumes readers include people in active use.]
Related: Xylazine, explained | Nitazenes Watch | How to use naloxone, step by step | Arizona’s Good Samaritan law.
Sources Cited
- 01.Ahttps://www.cdc.gov/stopoverdoseCDC Stop Overdose
- 02.A
Filed Under
NaloxoneFentanyl Test StripsOverdose
Keep up with the reporting.
One email each morning with the stories that put days like this in context.
Continue reading
More from this section
Xylazine Scheduling Didn't Shrink the Tranq Crisis. It Created a Worse One.
A new study links state xylazine scheduling to a surge in medetomidine, a more potent, harder-to-detect veterinary sedative now dominating drug supplies from Philadelphia to the Northeast.
Harm ReductionThe FDA Wants to Talk About Psilocybin's Future. It Won't Touch Who's Using It Right Now.
The FDA holds a public hearing today on psilocybin's therapeutic future while explicitly excluding legal status from the agenda — even as poison control calls and unsupervised use keep climbing.
Harm ReductionWashington Defunded Harm Reduction. The Newsroom Covering It Couldn't Outlast the Cut.
Filter Magazine, the nonprofit outlet that covered drug use as lived expertise, is shutting down four months after SAMHSA barred federal funds from syringes, pipes, and fentanyl test strips. The money and the storytelling are being cut together.